HRP20020330A2 - Novel oligosaccharides, preparation method and pharmaceutical compositions containing same - Google Patents
Novel oligosaccharides, preparation method and pharmaceutical compositions containing sameInfo
- Publication number
- HRP20020330A2 HRP20020330A2 HR20020330A HRP20020330A HRP20020330A2 HR P20020330 A2 HRP20020330 A2 HR P20020330A2 HR 20020330 A HR20020330 A HR 20020330A HR P20020330 A HRP20020330 A HR P20020330A HR P20020330 A2 HRP20020330 A2 HR P20020330A2
- Authority
- HR
- Croatia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- preparation
- containing same
- novel oligosaccharides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Virology (AREA)
- Polymers & Plastics (AREA)
- Psychology (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
Abstract
The invention concerns oligosaccharides of formula (I), their mixtures, their diastereomers, methods for preparing them and pharmaceutical compositions containing them.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9913182A FR2800074B1 (en) | 1999-10-22 | 1999-10-22 | NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
PCT/FR2000/002897 WO2001029055A2 (en) | 1999-10-22 | 2000-10-18 | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20020330A2 true HRP20020330A2 (en) | 2004-04-30 |
HRP20020330B1 HRP20020330B1 (en) | 2013-01-31 |
Family
ID=9551218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20020330A HRP20020330A2 (en) | 1999-10-22 | 2002-04-15 | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1226148B1 (en) |
JP (1) | JP4733329B2 (en) |
KR (2) | KR100778166B1 (en) |
CN (1) | CN1241932C (en) |
AT (1) | ATE534656T1 (en) |
AU (1) | AU781414B2 (en) |
BR (1) | BR0014939A (en) |
CA (1) | CA2388369C (en) |
CY (1) | CY1112274T1 (en) |
CZ (1) | CZ303255B6 (en) |
DK (1) | DK1226148T3 (en) |
EA (1) | EA004046B1 (en) |
EE (1) | EE05091B1 (en) |
ES (1) | ES2376409T3 (en) |
FR (1) | FR2800074B1 (en) |
HK (1) | HK1050535A1 (en) |
HR (1) | HRP20020330A2 (en) |
HU (1) | HU229385B1 (en) |
IL (2) | IL149154A0 (en) |
ME (1) | MEP9309A (en) |
MX (1) | MXPA02003945A (en) |
NO (1) | NO323409B1 (en) |
NZ (1) | NZ518539A (en) |
PL (1) | PL204623B1 (en) |
PT (1) | PT1226148E (en) |
RS (1) | RS50829B (en) |
SK (1) | SK287459B6 (en) |
TR (1) | TR200201102T2 (en) |
UA (1) | UA72545C2 (en) |
WO (1) | WO2001029055A2 (en) |
ZA (1) | ZA200203102B (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4676048B2 (en) * | 2000-07-10 | 2011-04-27 | 生化学工業株式会社 | Demyelinating disease treatment |
WO2002047696A1 (en) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Use of low molecular heparin for treating osteoarthritis |
DE10121003A1 (en) | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them |
AU2003225724A1 (en) | 2002-03-11 | 2003-09-29 | Momenta Pharmaceuticals, Inc. | Analysis of sulfated polysaccharides |
FR2844808B1 (en) * | 2002-09-23 | 2005-02-25 | Aventis Pharma Sa | METHOD OF DETERMINING SPECIFIC GROUPS CONSISTING OF HEPARINS OR HEPARINS OF LOW MOLECULAR WEIGHT |
US20040171819A1 (en) | 2002-10-10 | 2004-09-02 | Aventis Pharma S.A. | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
US7511026B2 (en) * | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
FR2857971B1 (en) * | 2003-07-24 | 2005-08-26 | Aventis Pharma Sa | MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US7956046B2 (en) * | 2003-07-24 | 2011-06-07 | Aventis Pharma S.A. | Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them |
US20050186679A1 (en) * | 2004-02-24 | 2005-08-25 | Christian Viskov | Method for determining specific groups constituting heparins or low molecular weight heparins |
EP1582531A1 (en) | 2004-03-24 | 2005-10-05 | Aventis Pharma S.A. | Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products |
EP1580197A1 (en) * | 2004-03-24 | 2005-09-28 | Aventis Pharma S.A. | Method for quantitatively determining specific groups constituting heparins or low molecular wieght heparins using HPLC |
DE102005017799A1 (en) * | 2005-04-18 | 2006-10-19 | Abbott Gmbh & Co. Kg | Use of heparin- or heparin derivative to treat illness associated with neurite plasticity or -growth defects, modulates interaction between Nogo receptor and ligands |
US8101733B1 (en) | 2006-06-27 | 2012-01-24 | Momenta Pharmaceuticals, Inc. | Methods of evaluating mixtures of polysaccharides |
US7968082B1 (en) | 2007-01-26 | 2011-06-28 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by NMR |
US7790466B1 (en) | 2007-01-26 | 2010-09-07 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping |
US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
EP2256138A1 (en) | 2009-05-05 | 2010-12-01 | Sanofi-Aventis | Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent |
FR2949114B1 (en) * | 2009-08-14 | 2011-08-26 | Sanofi Aventis | FGF RECEPTOR ACTIVATORY N-ACYLATED OCTASACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2949115B1 (en) * | 2009-08-14 | 2012-11-02 | Sanofi Aventis | FGF RECEPTOR ACTIVATOR N-SULFATE OLIGOSACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
US8435795B2 (en) | 2010-01-19 | 2013-05-07 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
WO2012115952A1 (en) | 2011-02-21 | 2012-08-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
CN102864191A (en) * | 2011-12-16 | 2013-01-09 | 深圳市海普瑞药业股份有限公司 | Heparin disaccharide mixture and preparation method and application thereof |
CN104910217B (en) * | 2015-06-19 | 2018-04-17 | 天津红日药业股份有限公司 | Reference compound for Fondaparinux sodium quality control |
CZ308106B6 (en) * | 2016-06-27 | 2020-01-08 | Contipro A.S. | Unsaturated derivatives of polysaccharides, preparing and using them |
CN110092848A (en) * | 2019-05-14 | 2019-08-06 | 山东辰龙药业有限公司 | A kind of preparation method of Bemiparin sodium |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2519987A1 (en) * | 1982-01-15 | 1983-07-22 | Choay Sa | Uronic acid derivs. - useful as glycoside intermediates or hapten(s) |
AU563351C (en) * | 1982-01-15 | 2003-06-19 | Glaxo Group Limited | Synthesis of oligosaccharides |
FR2764511B1 (en) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF ARTERIAL THROMBOSIS AND USE OF A FACTOR XA INHIBITOR ALONE AND / OR IN COMBINATION WITH A PLAQUET ANTIAGGREGANT |
JP4166851B2 (en) * | 1997-09-29 | 2008-10-15 | 生化学工業株式会社 | Novel inhibitor of ischemia / reperfusion injury |
-
1999
- 1999-10-22 FR FR9913182A patent/FR2800074B1/en not_active Expired - Fee Related
-
2000
- 2000-10-18 UA UA2002043067A patent/UA72545C2/en unknown
- 2000-10-18 PL PL363052A patent/PL204623B1/en not_active IP Right Cessation
- 2000-10-18 JP JP2001531853A patent/JP4733329B2/en not_active Expired - Fee Related
- 2000-10-18 RS YUP-298/02A patent/RS50829B/en unknown
- 2000-10-18 AT AT00969634T patent/ATE534656T1/en active
- 2000-10-18 MX MXPA02003945A patent/MXPA02003945A/en active IP Right Grant
- 2000-10-18 KR KR1020027005061A patent/KR100778166B1/en not_active IP Right Cessation
- 2000-10-18 EA EA200200479A patent/EA004046B1/en not_active IP Right Cessation
- 2000-10-18 CZ CZ20021385A patent/CZ303255B6/en not_active IP Right Cessation
- 2000-10-18 KR KR1020077018523A patent/KR100872215B1/en not_active IP Right Cessation
- 2000-10-18 CA CA2388369A patent/CA2388369C/en not_active Expired - Fee Related
- 2000-10-18 PT PT00969634T patent/PT1226148E/en unknown
- 2000-10-18 AU AU79302/00A patent/AU781414B2/en not_active Ceased
- 2000-10-18 TR TR2002/01102T patent/TR200201102T2/en unknown
- 2000-10-18 CN CNB008145318A patent/CN1241932C/en not_active Expired - Fee Related
- 2000-10-18 WO PCT/FR2000/002897 patent/WO2001029055A2/en active IP Right Grant
- 2000-10-18 NZ NZ518539A patent/NZ518539A/en not_active IP Right Cessation
- 2000-10-18 ME MEP-93/09A patent/MEP9309A/en unknown
- 2000-10-18 DK DK00969634.5T patent/DK1226148T3/en active
- 2000-10-18 EE EEP200200208A patent/EE05091B1/en not_active IP Right Cessation
- 2000-10-18 BR BR0014939-0A patent/BR0014939A/en active Pending
- 2000-10-18 ES ES00969634T patent/ES2376409T3/en not_active Expired - Lifetime
- 2000-10-18 SK SK527-2002A patent/SK287459B6/en not_active IP Right Cessation
- 2000-10-18 EP EP00969634A patent/EP1226148B1/en not_active Expired - Lifetime
- 2000-10-18 HU HU0203821A patent/HU229385B1/en unknown
- 2000-10-18 IL IL14915400A patent/IL149154A0/en active IP Right Grant
-
2002
- 2002-04-15 IL IL149154A patent/IL149154A/en not_active IP Right Cessation
- 2002-04-15 HR HR20020330A patent/HRP20020330A2/en not_active IP Right Cessation
- 2002-04-18 ZA ZA200203102A patent/ZA200203102B/en unknown
- 2002-04-19 NO NO20021859A patent/NO323409B1/en not_active IP Right Cessation
-
2003
- 2003-04-16 HK HK03102754A patent/HK1050535A1/en not_active IP Right Cessation
-
2012
- 2012-02-01 CY CY20121100113T patent/CY1112274T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20020330A2 (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same | |
DE60112609D1 (en) | Pyrazolopyridine | |
DE69726577D1 (en) | Kristallin form i von clarithromycin | |
PL366198A1 (en) | Novel compounds | |
HK1048990A1 (en) | Novel compounds. | |
DE60116761D1 (en) | Adamantanderivate | |
AU2002305143A1 (en) | Pyrazolo'1,5-a!pyridine derivatives | |
AP2002002458A0 (en) | Compounds for the treatment of ischemia. | |
HK1031869A1 (en) | 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds. | |
SE9901875D0 (en) | Novel compounds | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
HUP0103913A3 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
HK1030218A1 (en) | Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same. | |
IL117091A0 (en) | Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof | |
MXPA03001536A (en) | Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same. | |
NZ515108A (en) | Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments | |
YU10599A (en) | Amorphous benzothiophenes, procedure for the preparatio thereof and their pharmaceutical formulation | |
YU72802A (en) | Pharmaceutical compositions containing oligosaccharides and preparation thereof | |
DE60201074D1 (en) | Pyrazolopyridinderivate | |
AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
EP1132383A4 (en) | Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine | |
MXPA03010259A (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof. | |
CA2420056A1 (en) | 1-amino-alkylcyclohexanes as trypanocidal agents | |
PL332480A1 (en) | Novel heteroaruylooxyethylamines, method of obtaining them, their application as drugs as well as pharmaceutic compositions containing them | |
TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20130910 Year of fee payment: 14 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20141018 |